FDA Okays New Indication for Alirocumab in Homozygous FH
04/03/2021

FDA Okays New Indication for Alirocumab in Homozygous FH

The US Food and Drug Administration has approved alirocumab (Praluent, Regeneron Pharmaceutical...
read more